Mr. R. David Yost

• 
  www.smartbrief.com/news/aaaa/industryBW-detail.jsp?id=5 - [Cached Version]
  Published on: 5/10/2008    Last Visited: 5/10/2008  

  "To continue meeting the challenges of an ever changing pharmaceutical environment, AmerisourceBergen needs the infrastructure and cost structure that allows the Company to compete as the most efficient and effective operating company in our industry," said R. David Yost, AmerisourceBergen President and Chief Executive Officer."It is with that singular focus that we are further integrating our organization."
  
  The organizational changes, effective immediately are as follows:
  
  Michael D. DiCandilo, Executive Vice President and Chief Financial Officer of AmerisourceBergen, expands his responsibilities with the added position of Chief Operating Officer for AmerisourceBergen Drug Corporation (ABDC) and continues to report directly to Yost.
  ...
  Yost continues to lead ABDC and continues to have the executives leading sales and marketing reporting to him.
  ...
  Said Yost, "Terry has made an extraordinary contribution to AmerisourceBergen.
  ...
  Yost continues his executive leadership of Business Transformation.

• 
  www.renalbusiness.com/articles/07maynews04.html - [Cached Version]
  Published on: 5/1/2007    Last Visited: 2/3/2008  

  "Bellco is a great strategic fit with our pharmaceutical distribution business not only because of its strong position in the Metro New York City area, which is the largest independent retail community pharmacy market in the nation, but also because it brings a sophisticated generic pharmaceuticals sales and marketing business," said R. David Yost, AmerisourceBergen's CEO.
  
  Share this article: Email, Slashdot, Digg, Del.icio.us, Yahoo!MyWeb, Windows Live Favorites, Furl

• 
  www.amerisourcebergen.com/investor/phoenix.zhtml?c=6118 - [Cached Version]
  Published on: 2/27/2002    Last Visited: 11/6/2007  

  The four members elected to the Board today were: Rodney H. Brady, President and Chief Executive Officer of Deseret Management Corporation; Charles H. Cotros, Chairman and Chief Executive Officer of Sysco Corporation; Jane E. Henney, M.D., Senior Scholar in Residence at the Association of Academic Health Centers; and R. David Yost, President and Chief Executive Officer of AmerisourceBergen Corporation.

• 
  www.amerisourcebergen.com/investor/phoenix.zhtml?c=6118 - [Cached Version]
  Published on: 9/19/2003    Last Visited: 11/6/2007  

  R. David Yost, Chief Executive Officer of AmerisourceBergen, had these comments regarding the article.
  ...
  Participating in the conference call will be: R. David Yost, Chief Executive Officer; Kurt J. Hilzinger, President and Chief Operating Officer; and Michael D. DiCandilo, Senior Vice President and Chief Financial Officer.

• 
  www.twinpumpkins.com/v-cgi/feeds.cgi?feedid=226&story_i - [Cached Version]
  Published on: 3/31/2005    Last Visited: 8/8/2006  

  "This is a great transaction for PharMerica's employees," said R. David Yost, chief executive of AmerisourceBergen of Chesterbrook, Pa. "We're creating a company with great scale, which will enhance its ability to compete.And with growth, there will be great opportunity."Yost also said the new company is open to incentives that could determine where it will be based.Kindred's pharmacy business is headquartered in Louisville.
  
  "If you know anyone who can give us a tax subsidy, put them in touch with us," he told a reporter before flying to Tampa.

• 
  www.amerisourcebergen.com/investor/phoenix.zhtml?c=6118 - [Cached Version]
  Published on: 1/24/2003    Last Visited: 11/6/2007  

  "This was another outstanding quarter at AmerisourceBergen," said R. David Yost, AmerisourceBergen's Chief Executive Officer.
  ...
  "For the remainder of fiscal year 2003, we expect to grow operating revenue approximately 13 percent, and earnings per share 20 percent, excluding the impact of special items," said Yost."ROCC is expected to remain well above our 20 percent long-term target, and we remain confident in our ability to achieve annual merger integration cost savings of approximately $150 million by the end of fiscal year 2004, followed by additional cost savings as we complete the build out of our distribution network."
  
  Conference Call
  
  The Company will host a conference call to discuss the results at 11:00 a.m. Eastern Standard Time on January 24, 2003.Participating in the conference call will be: R. David Yost, Chief Executive Officer; Kurt J. Hilzinger, President and Chief Operating Officer; and Michael D. DiCandilo, Senior Vice President and Chief Financial Officer.

• 
  seattle.bizjournals.com/louisville/stories/2007/07/09/d - [Cached Version]
  Published on: 7/12/2007    Last Visited: 7/13/2007  

  AmerisourceBergen Corp., Kindred Healthcare Inc., Paul J. Diaz, R. David Yost, Edward L. Kuntz, Gregory S. Weishar,
  ...
  R. David Yost, CEO, AmerisourceBergen.

• 
  www.corporate-ir.net/ireye/ir_site.zhtml?ticker=abc&scr - [Cached Version]
  Published on: 5/11/2006    Last Visited: 3/21/2007  

  R. David Yost, Chief Executive Officer of AmerisourceBergen, added, "His strong management background in a highly competitive distribution business and his broad executive experience are valuable additions to the Company."

• 
  www.sec.gov/Archives/edgar/data/1140859/0000950123-09-0 - [Cached Version]
  Published on: 11/25/2009    Last Visited: 11/26/2009  

  R. David Yost
  ...
  Mr. Yost has been Chief Executive Officer and a Director of the Company since August 2001 and was President of the Company until October 2002. He again assumed the position of President of the Company in September 2007. He was Chief Executive Officer of AmeriSource Health Corporation from May 1997 until August 2001 and Chairman of the Board of AmeriSource from December 2000 until August 2001. Mr. Yost has been employed by the Company or one of its predecessors for 35 years.
  ...
  As required by Section 303A.12(a) of the New York Stock Exchange (“NYSE”) Listed Company Manual, our President and Chief Executive Officer, R. David Yost, certified to the NYSE within 30 days after our 2009 Annual Meeting of Stockholders that he was not aware of any violation by us of the NYSE Corporate Governance Listing Standards.

• 
  louisville.bizjournals.com/louisville/stories/2007/07/0 - [Cached Version]
  Published on: 7/12/2007    Last Visited: 7/13/2007  

  AmerisourceBergen Corp., Kindred Healthcare Inc., Paul J. Diaz, R. David Yost, Edward L. Kuntz, Gregory S. Weishar,
  ...
  R. David Yost, CEO, AmerisourceBergen.

Page:  1 2 3 4 5